By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Celsion Corporation 

997 Lenox Drive
Suite 100
Lawrenceville  New Jersey  08648  U.S.A.
Phone: 609-896-9100 Fax: 609-896-2200


Medical Device

Company News
Celsion (CLSN) Announces Enrollment Of First Patient In The OPTIMA Study In China 4/26/2016 6:47:06 AM
Celsion (CLSN) Presents Compelling Data At AACR 2016 Demonstrating Synergistic Anti-Cancer Effect Of GEN-1 IL-12 Immunotherapy Plus Avastin And Doxil 4/19/2016 6:39:08 AM
Celsion (CLSN) Announces Upcoming Presentation At AACR 2016 Highlighting Potential Of GEN-1 IL-12 Immunotherapy In Ovarian Cancer 4/12/2016 7:31:07 AM
Celsion (CLSN) Reports Year End 2015 Financial Results And Provides Business Update 3/30/2016 6:49:11 AM
Celsion (CLSN) To Hold Year-End 2015 Financial Results Conference Call On Wednesday, March 30, 2016 3/23/2016 7:52:18 AM
Celsion (CLSN) Announces Presentation Of Preclinical Data For GEN-1 IL-12 Immunotherapy In Combination With Avastin And Doxil At The AACR Annual Meeting 2016 3/17/2016 6:37:08 AM
Celsion (CLSN) Announces Launch Of The OPTIMA Study In China 3/7/2016 7:29:27 AM
Celsion (CLSN) Announces Issuance Of Key U.S. Patent Covering Its Novel TheraSilence RNA Program 3/1/2016 6:56:11 AM
Celsion (CLSN) Highlights Recent Pipeline Developments For Its GEN-1 Immunotherapy Program And Provides Business Update 2/12/2016 6:14:53 AM
Celsion (CLSN) Reports Translational Research Data From Its Phase 1b Study Of GEN-1 Immunotherapy In Recurrent Ovarian Cancer 1/7/2016 6:37:04 AM